beclabuvir 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
antivirals RNA polymerase (NS5B) inhibitors 5215 958002-33-0

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • beclabuvir
  • beclabuvir hydrochloride
  • beclabuvir HCl
  • BMS-791325
  • BMS 791325
an NS5B inhibitor and antiviral agent
  • Molecular weight: 659.85
  • Formula: C36H45N5O5S
  • CLOGP: 6.20
  • LIPINSKI: 2
  • HAC: 10
  • HDO: 1
  • TPSA: 104.19
  • ALOGS: -5.19
  • ROTB: 4

Drug dosage:

None

ADMET properties:

Approvals:

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Drug Use | Suggest Off label Use Form| |View source of the data|




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

External reference:

Pharmaceutical products:

None

beclabuvir